title: FDA allows second experimental drug to be tested in Ebola patients.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use*; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy*; D006801:Humans; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000998:Antiviral Agents; D015507:Drugs, Investigational; D034741:RNA, Small Interfering